Facial Plastic Surgery Controversies : Keloids - 09/04/18
Doi : 10.1016/j.fsc.2017.12.001
Kofi Boahene, MD a, Anthony E. Brissett, MD b, Lamont R. Jones, MD, MBA c, ⁎ 
a Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins Medical Institute, 601 North Caroline Street, Baltimore, MD 21287, USA
b Division of Facial Plastic and Reconstructive Surgery, Institute of Academic Medicine, Houston Methodist ENT and Facial Plastic Surgery Associates, Houston Methodist Hospital, 6550 Fannin Street, Suite 1703, Huston, TX 77030, USA
c Department of Otolaryngology–Head and Neck Surgery, Henry Ford Health Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
∗Corresponding author.
Résumé |
There are more than 11 million people in the world affected with keloids. Nevertheless, there is a lack of agreement in keloid management. Moreover, keloid research has left gaps in the understanding of its pathogenesis. Six questions are answered by 3 clinical scientists in an attempt to address common keloid controversies.
Le texte complet de cet article est disponible en PDF.Keywords : Keloid, Fibroproliferative tumor, Keloid treatment, Keloid risk factors, Keloid prophylaxis
Plan
| Disclosure Statement: The authors have nothing to disclose. |
© 2017
Elsevier Inc. Tous droits réservés.
Vol 26 - N° 2
P. 105-112 - mai 2018 Retour au numéro
Article précédent
- Controversies in Facial Plastic Surgery
- Fred G. Fedok, Robert M. Kellman
- Contemporary Laser and Light-Based Rejuvenation Techniques
- Mark Hamilton, Andrew Campbell, J. David Holcomb
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?